109685 ⎘
dsDNA viruses; Details; Adenoviridae; Mastadenovirus, e.g. human or simian adenoviruses; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Methods for prophylactically or therapeutically treating an animal for an ocular-related disorder
#1202Adenovirus vectors containing cell status-specific response elements and methods of use thereof
#1203Packaging cells for recombinant adenovirus
#1204Methods and compositions comprising DNA damaging agents and p53
#1205Cosmid vector
#1206Adenoviral vectors having a protein IX deletion
#1207Bidirectional promoters for small RNA expression
#1208Use of flexible bag containers for viral production
#1209Method of inducing an enhanced immune response against hiv
#1210Cancer immunotherapy incorporating p53
#1211Novel treatment of neurodegenerative diseases by altering levels of TrkB isoforms and/or TrkC isoforms
#1212Methods for treating, preventing, or reducing cardiac disorders using fadd inhibitors
#1213Development of a preventive vaccine for filovirus infection in primates
#1214Enhancement of adenoviral oncolytic activity by modification of the E1A gene product
#1215Selective induction of apoptosis to treat ocular disease
#1216Oncolytic adenovirus armed with therapeutic genes
#1217Selective inhibition of rock1 in cardiac therapy
#1218Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain
#1219Recombinant adenoviral vectors and methods of use
#1220Method of using adenoviral vectors with increased persistence in vivo
#1221Methods for inducing an immune response via oral administration of an adenovirus
#1222Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use
#1223Generation of replication competent viruses for therapeutic use
#1224Methods and vectors for controlling gene expression
#1225Neoadjuvant genetic compositions and methods
#1226Replication-competent adenoviral vectors
#1227Nell-1 enhanced bone mineralization
#1228Cells expressing recombinase useful for adenovirus vector production and control of gene expression
#1229MDA-7 and free radicals in the treatment of cancer
#1230Mechanisms of myoblast transfer in treating heart failure
#1231Methods and means for enhancing skin transplantation using gene delivery vehicles having tropism for primary fibroblasts, as well as other uses thereof
#1232Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors
#1233Recombinant expression of factor VIII in human cells
#1234Adenoviral vectors having a protein IX deletion
#1235Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
#1236Viral and non-viral vectors as vehicles for delivering transgenes for treating bone pathologies
#1237Novel use of adenoviruses and nucleic acids coding therefor
#1238High-efficiency wild-type-free AAV helper functions
#1239Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
#1240Compositions and methods of using angiopoietin-like 4 protein antibody
#1241Angiogenic factor and use thereof in treating cardiovascular disease
#1242Regulation of adenovirus DNA packaging by IPTG
#1243Adenovirus vectors for immunotherapy
#1244Telomelysin/GFP-expressing recombinant virus
#1245Ocular gene therapy
#1246Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses
#1247Production of adenovirus vectors with reduced levels of replication competent adenovirus contamination
#1248Fiber-modified adenoviral vectors for enhanced transduction of tumor cells
#1249Tissue specific expression
#1250Cytokine-expressing cellular vaccines for treatment of prostate cancer
#1251Connective tissue growth factor-2
#1252Combination treatment of cancer with elicitor of gene product expression and gene-product targeting agent
#1253Helper virus-free AAV production
#1254Bioprosthetic heart valves
#1255Adenoviral vectors having a protein IX deletion
#1256Modified viral vector particles
#1257Hybrid adeno-retroviral vector for the transfection of cells
#1258Adenoviral vectors having a protein IX deletion
#1259Replication-competent anti-cancer vectors
#1260Compositions and methods for treatment of lymphatic and venous vessel arterialization
#1261Adenovirus packaging cell lines
#1262Target cell-specific adenoviral vectors containing E3 and methods of use thereof
#1263Compositions comprising viruses and methods for concentrating virus preparations
#1264Method for treating cancer and increasing hematocrit levels
#1265Methods for treating pain
#1266Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus
#1267Vectors for tissue-specific replication
#1268Induction of apoptic or cytotoxic gene expression by adenoviral mediated gene codelivery
#1269Targeted adenovirus vectors for delivery of heterologous genes
#1270Method for producing recombinant adenovirus
#1271Cancer - targeted viral vectors
#1272Methods and compositions for treatment of interferon-resistant tumors
#1273Packaging cell line for diphtheria toxin expressing non-replicating adenovirus
#1274Oncolytic adenoviral vectors encoding GM-CSF
#1275Tumor-specific vector for gene therapy
#1276Method of reducing side effects of cancer therapy using p53 recombinant adenovirus
#1277Complementing cell lines
#1278Vectors and methods for gene transfer
#1279Reduction of dermal scarring
#1280Regulation of angiogenesis with zinc finger proteins
#1281Methods and compositions for treating neuropathic and neurodegenerative conditions
#1282Recombinant viral-based malaria vaccines
#1283Chimeric adenoviruses for use in cancer treatment
#1284Treatment of diabetes with synthetic beta cells
#1285PTHrP-derived modulators of smooth muscle proliferation
#1286Packaging systems for human recombinant adenovirus to be used in gene therapy
#1287Materials and methods for treating vascular leakage in the eye
#1288Compositions comprising viruses and methods for concentrating virus preparations
#1289Conditionally replicative adenovirus to target the Rb and Rb-related pathways
#1290Enzyme-prodrug therapy for prosthetic joint repair
#1291Use of VEGF-D gene to prevent restenosis
#1292Chimeric ebola virus envelopes and uses therefor
#1293Polynucleotide encoding human adenylylcyclase VI and uses thereof for enhancing cardiac function
#1294Engineered rnai adenovirus silencing expression (erase) of dna reair proteins
#1295Purification of adenovirus and AAV
#1296Adenovirus including a gene coding for a superoxide dismutase
#1297Genetic inhibition of epidermal growth factor receptor function and carcinoma cell radiosensitization
#1298Compositions and methods for treating cancer with an oncolytic viral agent
#1299Recombining viral vectors for the tetracycline-regulated expression of genes
#1300Serotype of adenovirus and uses thereof
#1301Methods for generating immunity to antigen
#1302Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer
#1303Materials and methods for treating ocular-related disorders
#1304Viruses with enhanced lytic potency
#1305Therapeutic anti-cancer DNA
#1306Pan cancer oncolytic vectors and methods of use thereof
#1307Cancer treatment by metabolic modulations
#1308Modified adenoviral vectors for use in vaccines and gene therapy
#1309Methods of adenovirus purification
#1310Adenoviral vector-mediated delivery of modified steroid hormone receptors and related products and methods
#1311Settings for recombinant adenoviral-based vaccines
#1312Coronary artery disease treatment
#1313Adenovirus formulations
#1314Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#1315Oncolytic adenoviral vectors encoding GM-CSF
#1316Gene delivery vectors with cell type specificity for mesenchymal stem cells
#1317Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content
#1318Methods of adenovirus production
#1319Adenovirus vector
#1320Formulation of adenovirus for gene therapy
#1321Anti-neoplastic viral agents
#1322Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses
#1323Recombinant protein production in permanent amniocytic cells that comprise nucleic acid encoding adenovirus E1A and E1B proteins
#1324Modulation of gastrointestinal epithelium proliferation through the Wnt signaling pathway
#1325Adeno-associated virus materials and methods
#1326Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
#1327Adenovirus vectors containing cell status-specific response elements and methods of use thereof
#1328Methods and means for producing proteins with predetermined post-translational modifications
#1329Accessory functions for use in recombinant AAV virion production
#1330Overexpression of enzymes involved in post-translational protein modifications in human cells
#1331Methods and compositions related to 1-caldesmon
#1332Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same
#1333Stable adenoviral vectors and methods for propagation thereof
#1334Methods and compositions for the production of adenoviral vectors
#1335Means and methods for the production of adenovirus vectors
#1336Methods of adenovirus purification
#1337Methods for the detection of cervical cancer
#1338Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
#1339Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site
#1340Viral vectors whose replication and, optionally, passenger gene are controlled by a gene switch activated by heat in the presence or absence of a small molecule regulator
#1341Method of identifying a gene product
#1342BAV packaging regions and E1 transcriptional control regions
#1343Hepatocellular carcinoma specific promoter and uses thereof
#1344System for producing clonal or complex populations of recombinant adenoviruses, and the application of the same
#1345Lipoparticles comprising proteins, methods of making, and using the same
#1346Vaccine using papilloma virus e proteins delivered by viral vector
#1347Methods of treating restenosis
#1348Methods of treating diabetes and other blood sugar disorders
#1349Vector system
#1350Efficient production of IgA in recombinant mammalian cells
#1351Use of AAV integration efficiency element for mediating site-specific integration of a transcription unit
#1352Therapeutic applications of thrombomodulin gene via viral and non-viral vectors
#1353Method of inducing an enhanced immune response against hiv
#1354Viral vector encoding pigment epithelium-derived factor
#1355Modified adenovirus containing a fiber replacement protein
#1356Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
#1357Method for the production and purification of adenoviral vectors
#1358Methods and compositions comprising DNA damaging agents and p53
#1359Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseases
#1360Serotype of adenovirus and uses thereof
#1361Construct of anti-cancer recombinant adenovirus, method for preparing the same and use thereof
#1362Synthetic human papilloma virus genes
#1363Packaging systems for human recombinant adenovirus to be used in gene therapy
#1364Viruses targeted to hypoxic cells and tissues
#1365Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modifications
#1366Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
#1367Recombinant adenoviruses encoding glial cell neurotrophic factor (GDNF)
#1368Adenoviral vector with replication-dependent transgene expression
#1369Systemic viral/ligand gene delivery system and gene therapy
#1370Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat
#1371Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
#1372Adenoviral vector system
#1373Method for the diagnosis and therapy of renal cell carcinoma
#1374Adenovirus E1B-55K single amino acid mutants and methods of use
#1375Method for treating fibrosis
#1376Specific proliferation in tumour cell which can express antioncogene with high efficiency and the use of it
#1377Methods for in vivo gene transfer into pancreatic and biliary epithelial cells
#1378Defective recombinant adenoviruses expressing cytokines for antitumor treatment
#1379p53 treatment of papillomavirus and carcinogen-transformed cells in hyperplastic lesions
#1380Subgroup B adenoviral vectors for treating disease
#1381Genetic modification of male germ cells for generation of transgenic species & genetic therapies
#1382Vectors and methods for immunization or therapeutic protocols
#1383Tumor suppression through bicistronic co-expression of p53 and p14ARF
#1384Cell-specific expression/replication vector
#1385Composition for viral preservation
#1386Tumor-specific promotor and use thereof
#1387Adenoviral vectors having a protein IX deletion
#1388Diminishing viral gene expression by promoter replacement
#1389Deleted adenovirus vectors and methods of making and administering the same
#1390Device for cultivating cells and propagating viruses
#1391In vivo production of a clostridial neurotoxin light chain peptide
#1392Nucleic acid delivery
#1393Vaccine containing the catalytic subunit of telomerase for treating cancer
#1394Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site
#1395Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof
#1396Viral uptake into cells and tissues
#1397Adenovirus packaging cell lines
#1398Adenoviral E1A/E1B complementing cell line
#1399Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus
#1400Gene therapy using replication competent targeted adenoviral vectors
#1401Recombinantly-modified adeno-associated virus (rAAV) having improved packaging efficiency
#1402Self-replicating cell selective gene delivery compositions, methods, and uses thereof
#1403Vaccines for herpes simplex virus 1 and 2
#1404TAA/ecdCD40L oncolytic virus